Latest News

QPM Energy Limited ( ASX:QPM ) shareholders would be excited to see that the share price has had a great month, posting...

Some Saunders International Limited ( ASX:SND ) shareholders may be a little concerned to see that insider Timothy...

Viridis Mining and Minerals Limited ( ASX:VMM ) insiders who purchased shares in the last 12 months were richly...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sociedad Química y Minera de Chile fair value estimate is...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Golconda Gold (CVE:GG) has had a great run on the share market with its stock up by a significant 206% over the last...

Amidst a turbulent Australian market, with headline inflation climbing to 3% and mixed performances across sectors, investors are navigating a landscape where utilities and energy show resilience while financials face downward pressure. In such an environment, identifying stocks with strong potential often involves finding companies that can thrive despite broader economic challenges, making them true undiscovered gems in the market.

We wouldn't blame Brookfield Corporation ( TSE:BN ) shareholders if they were a little worried about the fact that...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Pentair fair value estimate is US$104 Pentair's US$110 share...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

As the Canadian market navigates through a period of uncertainty, with central banks offering limited guidance on future policy directions, investors are keeping a close eye on economic indicators to gauge potential interest rate cuts. In such volatile times, penny stocks—despite their somewhat outdated moniker—remain an intriguing investment area due to their affordability and growth potential. These smaller or newer companies can offer significant returns when backed by strong financials,...

Key Insights The projected fair value for Meridian Energy is NZ$9.21 based on 2 Stage Free Cash Flow to Equity Current...

Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...

Koninklijke Ahold Delhaize’s consensus analyst price target has seen only a slight increase, moving from €35.90 to €36.47. Analysts remain divided, with some cautious voices citing margin pressures and competitive challenges. Others highlight ongoing resilience and disciplined management as reasons to support the stock’s valuation. Stay tuned to discover how you can keep up with the evolving narrative around Ahold Delhaize’s market outlook. What Wall Street Has Been Saying Analyst commentary...

Thinking about what to do with Corpay stock? You are not alone; it has been a hot topic ever since recent price swings caught the attention of both cautious investors and growth optimists. Over just the past week, Corpay saw its shares dip by 2.7%, and that slide stretches to a 10.0% drop for the last 30 days. Year-to-date, the stock is down 12.3%. These moves might have some people concerned, but to put things in perspective, Corpay has still returned a solid 70.9% over three years, along...

As the U.S. stock market experiences fluctuations with tech shares declining and energy sectors outperforming, investors are keenly observing the Federal Reserve's recent interest rate cut and its implications on stock valuations. In this environment, identifying stocks that may be priced below their intrinsic value can offer opportunities for those looking to navigate these shifting market dynamics effectively.

As major U.S. stock indexes experience declines, particularly in the tech sector, and energy stocks outperform due to rising crude futures, investors are keenly observing market fluctuations and valuations. In this environment, growth companies with strong insider ownership can be appealing as they often signal confidence from those closest to the business.

As the U.S. stock market experiences a mixed performance with tech shares declining and the energy sector outperforming, investors are exploring diverse opportunities to navigate these fluctuating conditions. Penny stocks, despite their somewhat outdated name, continue to attract attention due to their potential for significant returns when backed by solid financials. This article examines three penny stocks that stand out for their financial strength and potential for growth, offering...

Nu Skin Enterprises recently reported progress in operational efficiency, innovation, and international expansion, highlighted by growth in its Rhyz Manufacturing segment and anticipation for the AI-powered Prysm iO device. This operational momentum is fueling greater user interest, especially as product innovation and technology integrations shape future customer engagement. We’ll explore how the upcoming Prysm iO device supports Nu Skin Enterprises’ investment narrative and potential for...

Despite an already strong run, Alibaba Group Holding Limited ( NYSE:BABA ) shares have been powering on, with a gain of...

If you've been watching Kingsgate Consolidated (ASX:KCN), the last few days may have caught your attention. The company has just been added to both the S&P/ASX Small Ordinaries Index and the S&P/ASX 300 Index, two moves that often lead to fresh investment flows and shine a brighter spotlight on a stock. With Kingsgate set to present at the upcoming ASX SMIDcaps Conference, the stage seems set for more updates, which could potentially influence how the market views its growth prospects. These...

So, you’ve been following Zijin Mining Group (SEHK:2899) and are wondering if now is the time to make a move. The company just hit a major milestone, launching production at its Tres Quebradas lithium project in Argentina. This isn’t just a ribbon-cutting moment; it marks Zijin stepping further into the global battery materials space at a time when demand for electric vehicle batteries is hitting new highs. With over USD 600 million invested in development since acquiring the asset in 2022,...

Ypsomed Holding has seen its consensus analyst price target dip from CHF463.26 to CHF449.37, reflecting mixed analyst sentiment. Recent commentary highlights both bullish confidence in Ypsomed's leadership in the injectable market, as well as caution from others who question the sustainability of its growth following a company transformation. Stay tuned to discover how you can keep up with shifts in the evolving narrative for Ypsomed Holding stock. What Wall Street Has Been Saying Analyst...

In September 2025, Aquestive Therapeutics announced that the FDA will not require an advisory committee meeting for its Anaphylm sublingual epinephrine film, clearing a smoother regulatory path toward a potential launch. This decision signals increased confidence in both the product's regulatory prospects and the potential for accelerated adoption of needle-free epinephrine treatments. We'll explore how this clear regulatory pathway for Anaphylm could reshape Aquestive Therapeutics'...